Skip to content

Author

M. Müther

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

[18F]FET uptake in diffuse lower-grade IDH-mutant glioma correlates with glioma-related epilepsy

Diffuse lower-grade glioma (DLGG), i.e. WHO grade 2 and 3 tumors, frequently manifests with epileptic seizures, significantly affecting quality of life. While [18F]FET PET is routinely used to assess glioma metabolism, differences between patients with and without glioma-related epilepsy have not yet been assessed syst...

Z. Özdemir, Wolfgang Roll, Walter Stummer et al. · 0 citations
Sep 2026

Identification of prognostically relevant residual tumor in glioblastoma after surgery: A comparative analysis of MR-based RANO resect classes vs. [18F]FET PET.

BACKGROUND Assessment of postoperative tumor burden is essential in IDH-wildtype glioblastoma. The RANO resect classification stratifies patients based on residual tumor volume on postoperative MRI. [¹⁸F]FET PET can detect metabolically active tumor-suspicious tissue invisible on MRI. Its additional prognostic contribu...

J. Blobner, Katharina J. Schmidbauer, M. Müther et al. · 0 citations
Open access Sep 2026

A multicenter analysis of prognostic factors for patients undergoing re-irradiation for recurrent glioblastoma

Re-irradiation (re-RT) has gained popularity in the treatment of recurrent or progressive glioblastoma (rGBM) after first-line treatment. However, uncertainties regarding optimal treatment dose, fraction size and target volume definition remain. In this multicenter analysis of the Western German Cancer Center (WT...

N. Pepper, M. Guberina, C. Poettgen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.